The Congressional Budget Office's Case for Comparative Effectiveness

There's a lot of support for a federal comparative effectiveness agency, but would it actually curtail health care spending? The head of CBO says yes--when paired with the appropriate incentives.

By Peter Orszag

Too much of the public discussion about the nation’s long-term fiscal imbalance is about Society Security, Medicare and Medicaid, in...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet